Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Trevena
Work at Trevena?
Add yourself to this profile
77
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Edit Profile
trevenainc.com
Technology
>
Biotechnology
B2b
Founded in
2007
Raised
$164M
More info
Elsewhere
Companies in the same industry
UWI Technology
Prenetics
JumpStartInc
Imaging3 Inc
Merganser Biotech, Inc.
Champions Oncology
hadas
RaNA Therapeutics
Editas Medicine
TerViva
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Latest funding
Show all
Post-IPO equity
$45,000,000
Venture capital (Series C)
$60,000,000
Forest Laboratories
Employees
Team size
10+
Locations
Unknown
Help us complete this profile
The Motley Fool
Here's Why Trevena Stock Dropped 18% Today
The Motley Fool
Why Trevena Inc.'s Shares Broke Through Today
Health
Stock markets
UWI Technology
Prenetics
JumpStartInc
Imaging3 Inc
Champions Oncology
hadas
RaNA Therapeutics
Editas Medicine